Conmed Corp. - Ordinary Shares

134.09-1.59-1.17%Vol 187.70K1Y Perf 85.63%
Apr 9th, 2021 16:00 DELAYED
BID35.17 ASK0.0000
Open136.00 Previous Close135.68
Pre-Market- After-Market134.09
 - -  - -%
Target Price
129.25 
Analyst Rating
Moderate Buy 2.00
Potential %
-3.61 
Finscreener Ranking
     35.45
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     34.45
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     43.99
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
+     26.99
Market Cap3.88B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
97.08 
Earnings Date
28th Apr 2021

Today's Price Range

133.54136.19

52W Range

60.65136.30

5 Year PE Ratio Range

25.30119.80

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
3.52%
1 Month
8.31%
3 Months
18.77%
6 Months
56.01%
1 Year
85.63%
3 Years
116.73%
5 Years
226.46%
10 Years
429.04%

TickerPriceChg.Chg.%
CNMD134.09-1.5900-1.17
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
1.10
2.20
0.51
1.09
1.00
Leverage Ratio 2.50
ProfitabilityValueIndustryS&P 500US Markets
53.40
5.30
13.70
4.10
0.47
RevenueValueIndustryS&P 500US Markets
648.45M
22.40
2.91
4.78
DividendsValueIndustryS&P 500US Markets
0.61
0.80
0.00
0.00
Payout ratio70.00
Earnings HistoryEstimateReportedSurprise %
Q04 20200.780.847.69
Q03 20200.250.88252.00
Q02 2020-1.02-0.0793.14
Q01 20200.440.5115.91
Q04 20190.890.901.12
Q03 20190.560.6210.71
Q02 20190.530.565.66
Q01 20190.540.575.56
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.43-31.75Negative
6/2021 QR0.61-16.44Negative
12/2021 FY2.95-3.91Negative
12/2022 FY3.63-2.16Negative
Next Report Date28th Apr 2021
Estimated EPS Next Report0.43
Estimates Count5
EPS Growth Next 5 Years %9.90
Volume Overview
Volume187.70K
Shares Outstanding28.94M
Trades Count3.52K
Dollar Volume30.92M
Avg. Volume273.73K
Avg. Weekly Volume276.38K
Avg. Monthly Volume268.56K
Avg. Quarterly Volume268.79K

Conmed Corp. - Ordinary Shares (NASDAQ: CNMD) stock closed at 134.09 per share at the end of the most recent trading day (a -1.17% change compared to the prior day closing price) with a volume of 187.74K shares and market capitalization of 3.88B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3400 people. Conmed Corp. - Ordinary Shares CEO is Curt R. Hartman.

The one-year performance of Conmed Corp. - Ordinary Shares stock is 85.63%, while year-to-date (YTD) performance is 19.72%. CNMD stock has a five-year performance of 226.46%. Its 52-week range is between 60.65 and 136.3, which gives CNMD stock a 52-week price range ratio of 97.08%

Conmed Corp. - Ordinary Shares currently has a PE ratio of 435.30, a price-to-book (PB) ratio of 5.33, a price-to-sale (PS) ratio of 5.85, a price to cashflow ratio of 59.60, a PEG ratio of 2.32, a ROA of 0.52%, a ROC of 2.16% and a ROE of 1.28%. The company’s profit margin is 0.47%, its EBITDA margin is 13.70%, and its revenue ttm is $648.45 Million , which makes it $22.40 revenue per share.

Of the last four earnings reports from Conmed Corp. - Ordinary Shares, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.43 for the next earnings report. Conmed Corp. - Ordinary Shares’s next earnings report date is 28th Apr 2021.

The consensus rating of Wall Street analysts for Conmed Corp. - Ordinary Shares is Moderate Buy (2), with a target price of $129.25, which is -3.61% compared to the current price. The earnings rating for Conmed Corp. - Ordinary Shares stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Conmed Corp. - Ordinary Shares has a dividend yield of 0.61% with a dividend per share of $0.80 and a payout ratio of 70.00%.

Conmed Corp. - Ordinary Shares has a Buy technical analysis rating based on Technical Indicators (ADX : 9.29, ATR14 : 4.98, CCI20 : 78.70, Chaikin Money Flow : 0.10, MACD : 1.66, Money Flow Index : 61.29, ROC : -0.08, RSI : 56.77, STOCH (14,3) : 59.10, STOCH RSI : 0.90, UO : 53.62, Williams %R : -40.90), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Conmed Corp. - Ordinary Shares in the last 12-months were: Barbara J Schwarzentraub (Option Excercise at a value of $0), Brian P. Concannon (Option Excercise at a value of $0), Brian P. Concannon (Sold 3 036 shares of value $271 145 ), Charles M. Farkas (Option Excercise at a value of $0), Curt R. Hartman (Sold 0 shares of value $-10 844 640 ), Curt R. Hartman (Sold 35 000 shares of value $3 858 870 ), Daniel S. Jonas (Option Excercise at a value of $1 071 334), Daniel S. Jonas (Sold 21 073 shares of value $2 175 558 ), David M. Bronson (Option Excercise at a value of $0), Heather L. Cohen (Option Excercise at a value of $353 340), Jerome J. Lande (Option Excercise at a value of $0), John E. Kennedy (Option Excercise at a value of $2 260 760), John E. Kennedy (Sold 37 658 shares of value $3 571 271 ), John L. Workman (Option Excercise at a value of $0), Johonna Pelletier (Option Excercise at a value of $1 302 481), Johonna Pelletier (Sold 26 056 shares of value $2 943 928 ), LaVerne Council (Option Excercise at a value of $0), Mark E. Tryniski (Option Excercise at a value of $387 777), Mark E. Tryniski (Sold 8 265 shares of value $1 004 863 ), Martha Goldberg Aronson (Option Excercise at a value of $0), Peter K. Shagory (Sold 0 shares of value $-353 129 ), Peter K. Shagory (Sold 8 640 shares of value $736 173 ), Stanley W. Peters (Sold 0 shares of value $-637 920 ), Stanley W. Peters (Sold 16 500 shares of value $1 636 250 ), Terence M. Berge (Option Excercise at a value of $2 583 877), Terence M. Berge (Sold 66 458 shares of value $7 065 760 ), Todd W. Garner (Option Excercise at a value of $0), Wilfredo Ruiz-Caban (Sold 0 shares of value $-1 686 103 ), Wilfredo Ruiz-Caban (Sold 9 919 shares of value $813 556 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (50.00 %)
3 (50.00 %)
3 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (50.00 %)
3 (50.00 %)
3 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

Conmed Corp. - Ordinary Shares

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.

CEO: Curt R. Hartman

Telephone: +1 727 392-6464

Address: 11311 Concept Boulevard, Largo 33773, FL, US

Number of employees: 3 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

52%48%

Bearish Bullish

48%52%

News

Stocktwits